Vulnerability in Novastar Novaicare
CVE-2021-38289
An issue has been discovered in Novastar-VNNOX-iCare Novaicare 7.16.0 that gives attacker privilege escalation and allows attackers to view corporate information and SMTP server details, delete users, view roles, and other unspecified impacts. NOTE: As of April 2026, the vendor has officially decommissioned the affected legacy endpoints and associated services. The vulnerability is mitigated as the functional logic is no longer operational and the URLs have been removed from production.
EPSS: 0.014 (70.0th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
Affected products
- Novastar Novaicare — versions 7.16.0
- N/a — versions n/a
Weakness classification (CWE)
References
- cve@mitre.org (Exploit, Third Party Advisory)
- cve@mitre.org (Exploit, Third Party Advisory)
- cve@mitre.org
Frequently asked questions
- What is CVE-2021-38289?
- CVE-2021-38289 is a high-severity vulnerability in Novastar Novaicare, classified under Incorrect Permission Assignment for Critical Resource. CVSS score: 8.8/10. Published 2022-07-12.
- How severe is CVE-2021-38289?
- High severity. CVSS v3 base score is 8.8 out of 10.